PPARA and obesity due to melanocortin 4 receptor deficiency: Oleoylethanolamide (OEA) has been shown to directly alter lipid metabolism via peroxisome proliferator-activated receptor alpha (PPARα)21, resulting in anti-obesity properties, such as lower body weight, as well as decreased lipid levels in circulation and the liver22.